ArticleJournal of molecular neuroscience : MN2020

HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma.

Mariane da Cunha Jaeger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.